FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |   Search Term  Advanced Search

Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe

Previous Volume 356:2639-2641 June 21, 2007 Number 25 Next

	Since this article has no abstract, we have provided an extract of the first 100 words of the full text and any section headings.

	Full Text PDF PDA Full Text Purchase this article Letters Add to Personal Archive Add to Citation Manager Notify a Friend E-mail When Cited E-mail When Letters Appear Related Article by Manson, J. E. PubMed Citation

For the past decade, women and health care providers have faced confusing information about the effects of hormone-replacement therapy, or HRT, on heart disease. Important practical questions have remained unresolved: Who can safely receive hormone-replacement therapy? Who is at increased risk from hormone-replacement therapy? Might any women benefit from hormone-replacement therapy for reasons other than relief from menopausal symptoms?

Now, some clarity about hormone-replacement therapy and heart disease is emerging. New research supports the concept that hormone-replacement therapy has different effects on blood vessels in younger menopausal women (50 to 59 years old) than in women long after menopause, underscoring . . . [Full Text of this Article]

Source Information

From the Molecular Cardiology Research Institute, Tufts–New England Medical Center, Tufts University School of Medicine, Boston.

Related Letters:

Estrogen Therapy and Coronary-Artery Calcification
Hodis H. N., Mack W. J., Brouwer M. A., Dieker H.-J., Verheugt F. W.A., Hofbauer L. C., Khosla S., Schoppet M., Manson J. E., Allison M. A., Rossouw J. E.
Extract | Full Text | PDF  
N Engl J Med 2007; 357:1252-1254, Sep 20, 2007. Correspondence

This article has been cited by other articles:

• Gavin, K. M., Seals, D. R., Silver, A. E., Moreau, K. L. (2009). Vascular Endothelial Estrogen Receptor {alpha} Is Modulated by Estrogen Status and Related to Endothelial Function and Endothelial Nitric Oxide Synthase in Healthy Women. J. Clin. Endocrinol. Metab. 94: 3513-3520 [Abstract] [Full Text]  
• Meyer, M. R., Barton, M. (2009). ER{alpha}, ER{beta}, and gpER: novel aspects of oestrogen receptor signalling in atherosclerosis. Cardiovasc Res 83: 605-610 [Full Text]  
• Greendale, G. A., Huang, M-H, Wight, R. G., Seeman, T., Luetters, C., Avis, N. E., Johnston, J., Karlamangla, A. S. (2009). Effects of the menopause transition and hormone use on cognitive performance in midlife women. Neurology 72: 1850-1857 [Abstract] [Full Text]  
• Schindler, T. H., Campisi, R., Dorsey, D., Prior, J. O., Olschewski, M., Sayre, J., Schelbert, H. R. (2009). Effect of hormone replacement therapy on vasomotor function of the coronary microcirculation in post-menopausal women with medically treated cardiovascular risk factors. Eur Heart J 30: 978-986 [Abstract] [Full Text]  
• Xing, D., Nozell, S., Chen, Y.-F., Hage, F., Oparil, S. (2009). Estrogen and Mechanisms of Vascular Protection. Arterioscler. Thromb. Vasc. Bio. 29: 289-295 [Abstract] [Full Text]  
• Billon-Gales, A., Fontaine, C., Filipe, C., Douin-Echinard, V., Fouque, M.-J., Flouriot, G., Gourdy, P., Lenfant, F., Laurell, H., Krust, A., Chambon, P., Arnal, J.-F. (2009). The transactivating function 1 of estrogen receptor {alpha} is dispensable for the vasculoprotective actions of 17{beta}-estradiol. Proc. Natl. Acad. Sci. USA 106: 2053-2058 [Abstract] [Full Text]  
• Shufelt, C. L., Bairey Merz, C. N. (2009). Contraceptive hormone use and cardiovascular disease.. J Am Coll Cardiol 53: 221-231 [Abstract] [Full Text]  
• Schnoes, K. K., Jaffe, I. Z., Iyer, L., Dabreo, A., Aronovitz, M., Newfell, B., Hansen, U., Rosano, G., Mendelsohn, M. E. (2008). Research Resource: Rapid Recruitment of Temporally Distinct Vascular Gene Sets by Estrogen. Mol. Endocrinol. 22: 2544-2556 [Abstract] [Full Text]  
• Matyal, R. (2008). Newly Appreciated Pathophysiology of Ischemic Heart Disease in Women Mandates Changes in Perioperative Management: A Core Review. Anesth. Analg. 107: 37-50 [Abstract] [Full Text]  
• Miller, V. M., Duckles, S. P. (2008). Vascular Actions of Estrogens: Functional Implications. Pharmacol. Rev. 60: 210-241 [Abstract] [Full Text]  
• Campbell, D. J. (2008). Why do men and women differ in their risk of myocardial infarction?. Eur Heart J 29: 835-836 [Full Text]  
• Jackson, G. (2008). Gender differences in cardiovascular disease prevention. Menopause Int 14: 13-17 [Abstract] [Full Text]  
• Jacobson, P. D. (2008). Transforming Clinical Practice Guidelines Into Legislative Mandates: Proceed With Abundant Caution. JAMA 299: 208-210 [Full Text]  
• Hodis, H. N., Mack, W. J., Brouwer, M. A., Dieker, H.-J., Verheugt, F. W.A., Hofbauer, L. C., Khosla, S., Schoppet, M., Manson, J. E., Allison, M. A., Rossouw, J. E. (2007). Estrogen Therapy and Coronary-Artery Calcification. NEJM 357: 1252-1254 [Full Text]  
• Roberts, H. (2007). Hormone replacement therapy comes full circle. BMJ 335: 219-220 [Full Text]  
• (2007). Estrogen Therapy Mitigates Risk for Coronary Artery Disease in Younger Menopausal Women. JWatch Women's Health 2007: 2-2 [Full Text]  
• (2007). More from the Women's Health Initiative: Benefits for Estrogen?. JWatch General 2007: 1-1 [Full Text]